Ad
related to: vertex new york times- Full Digital Access
Get Unlimited Access to WSJ on Any
of Your Devices Wherever You Are.
- Home Delivery of the WSJ
Get WSJ Delivered to Your Door
6 Days a Week. View Options.
- View Subscription Options
Lock in Savings, or View
Other Subscription Options.
- WSJ Digital Bundle
Three Best In Class Subscriptions.
Subscribe today for $1 per week.
- Exclusive Student Offer
WSJ Offers A Discounted Rate For
Students & Faculty. Find Out More.
- Why WSJ
Get Full Access to the News you can
Trust and Insights you can use
- Full Digital Access
Search results
Is Vertex Pharmaceuticals Stock Too Expensive With a Price-to-Sales Ratio of 11x?
Motley Fool via Yahoo Finance· 3 months agoI've been a big fan of Vertex Pharmaceuticals (NASDAQ: VRTX), and the biotech stock has made me a...
York board declines to vote for cell tower. Vertex argues federal law overrules town.
Portsmouth Herald via Yahoo News· 2 years agoYORK, Maine — Vertex Towers could not convince the town's Planning Board last week to consider an...
IBD 50 Stocks To Watch: Vertex Pharmaceuticals In Buy Zone As Firm Gets On A Roll
Investor's Business Daily· 1 year agoBiotech stock Vertex Pharmaceuticals is in the buy zone of a base. Vertex stock is Tuesday's IBD 50...
Vertex Towers threatens lawsuit if York rejects 120-foot cell tower project
Portsmouth Herald via Yahoo News· 2 years agoYORK, Maine — A wireless infrastructure company is threatening legal action in federal court if the...
Vertex Pharmaceuticals: Buy at the High?
Motley Fool· 2 years agoVertex Pharmaceuticals (NASDAQ: VRTX) has a lot going on these days. The biotech company is developing two candidates that could make it even stronger in...
York rejects 120-foot cell tower to fix dead zone: Here’s why and what comes next
Portsmouth Herald via Yahoo News· 2 years agoYORK, Maine — A proposed new cell tower in York Village hit a dead zone last week after the town's...
New Non-Opioid Drug Blocks Pain Signals Before They Can Reach Brain
Futurism via Yahoo News· 4 months agoAs the opioid crisis worsens, one Boston-based pharmaceutical company has used some impressive...
Bluebird, Vertex prep for first commercial use of sickle cell gene therapies
BioPharma Dive via Yahoo Finance· 3 weeks agoPhysicians at Children’s National Hospital in Washington, D.C., last week collected the stem cells...
Hampton ZBA stands firm on cell tower denial: Will Vertex sue town?
Portsmouth Herald via Yahoo News· 3 months agoHAMPTON — The town’s Zoning Board voted unanimously Monday to reject a rehearing request from a...
FDA approves cure for sickle cell disease, the first treatment to use CRISPR
NBC News via Yahoo News· 6 months agoThe Food and Drug Administration on Friday approved a powerful treatment for sickle cell disease, a...
